Whither pentoxifylline?

Critical Care Medicine

Volumn 27, Issue 1, 1999, Pages 19-20

  Fink, Mitchell P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Close dependent effects; Pentoxifylline; Peritonitis, subacute bacterial; Phosphodiesterase IV

Indexed keywords

BETA ACTIN; COMPLEMENTARY DNA; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MESSENGER RNA; PENTOXIFYLLINE; PHOSPHODIESTERASE IV; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; BACTERIAL PERITONITIS; BORRELIA INFECTION; BORRELIA RECURRENTIS; CLINICAL TRIAL; CYTOKINE PRODUCTION; DOSE RESPONSE; EDITORIAL; HUMAN; KIDNEY CARCINOMA; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SURVIVAL RATE;

ANIMALS; BACTEREMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; PENTOXIFYLLINE; PERITONITIS; PHOSPHODIESTERASE INHIBITORS; RATS;

EID: 0032917571     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199901000-00013     Document Type: Editorial

References (17)

1. 1. Liang L, Beshay E, Prud'homme GJ: The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice. Diabetes 1998; 47:570-575
2. 2. Doherty GM, Jensen JC, Alexander HR, et al: Pentoxifilline suppression of tumor necrosis factor gene transcription. Surgery 1991; 110:192-198
3. 3. Badger AM, Olivera DL, Esser KM: Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock. Circ Shock 1994; 44:188-195
4. 4. Schade UF: Pentoxifilline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor. Circ Shock 1990; 31:171-181
5. 5. Netea MG, Blok WL, Kullberg BJ, et al: Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. J Infect Dis 1995; 171:393-399
6. 6. Lechner AJ, Rouben LR, Potthoff LH, et al: Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock. Circ Shock 1993; 39:306-315
7. 7. Lee KS, Cottam HB, Houglum K, et al: Pentoxifylline blocks hepatic stellate cell activation independently of phosphodiesterase inhibitory activity. Am J Physiol 1997; 273:G1094-G1100
8. 8. Nelson JL, Alexander JW, Mao J-X, et al: The effect of pentoxifylline on survival and intestinal cytokine mRNA transcription in a rat model of ongoing peritoneal sepsis. Crit Care Med 1999; 27:113-119
9. 9. Chalkiadakis GE, Kostakis A, Karayannacos PE, et al: Pentoxifylline in the treatment of experimental peritonitis in the rat. Arch Surg 1998; 120:1141-1144
10. 10. Hadjiminas DJ, McMasters KM, Robertson SE, et al: Enhanced survival from cecal ligation and puncture with pentoxyfylline is associated with altered neutrophil trafficking and reduced interleukin-1β expression but not inhibition of tumor necrosis factor synthesis. Surgery 1994; 116:348-355
11. 11. Wenisch C, Looareesuwan S, Wilairatana P, et al: Effect of pentoxifylline on cytokine patterns in the therapy of complicated Plasmodium falciparum malaria. Am J Trop Med Hyg 1998; 58:343-347
12. 12. Delers F, Mangeney M, Raffa D, et al: Changes in rat liver mRNA for at-acid-glycoprotein, apolipoprotein E, apolipoprotein B, and β-actin after mouse recombinant tumor necrosis factor injection. Biochem Biophys Res Commun 1989; 161:81-88
13. 13. Kohno H, Hamanaka R, Abe T, et al: Morphological change and destabilization of β-actin mRNA by tumor necrosis factor in human microvascular endothelial cells. Exp Cell Res 1993; 208:498-503
14. 14. Staubach KH, Schroder J, Stuber F, et al: Effect of pentoxifilline in severe sepsis: results of a randomized, double-blind, placebo-controlled study. Arch Surg 1998; 133:94-100
15. 15. Rini BI, Stadler WM, Spielberger RT, et al: Granulocyte-macrophage-colony stimulating factor in metastatic renal cell carcinoma: A phase II trial. Cancer 1998; 82:1352-1358
16. 16. Martich GD, Parker MM, Cunnion RE, et al: Effects of ibuprofen and pentoxifylline on the cardiovascular response of normal humans to endotoxin. J Appl Physiol 1992; 73:925-931
17. 17. Remick DG, Negussie Y, Fekade D, et al: Pentoxifylline fails to prevent the Jarisch-Herxheimer reaction or associated cytokine release. J Infect Dis 1996; 174:627-630